Tine to Change Logo

The information on this page was last updated on 11 January 2022.

The company’s shares are only traded on the London Stock Exchange’s AIM market at present.

The number of shares in issue is 182,236,776 ordinary shares of 10 pence each. No ordinary shares are held as treasury shares and therefore the total number of voting rights in the Company is 182,236,776.

There are no restrictions on the transfer of securities.

As far as the Company is aware, the percentage of the Company’s issued share capital not in public hands (as defined by the AIM Rules for Companies) is 22.8%.

In so far as the Company has been notified, the Company’s significant (3% or larger) shareholders are as follows.

Name Number
of shares
% of total
Richard Sneller 20,274,500 11.13%
Stonehage Fleming Investment Management Ltd 18,390,000 10.09%
Columbia Threadneedle Investments 11,532,834 6.33%
Premier Milton Group plc 8,529,969 4.68%
Liontrust Investment Partners LLP 8,136,423 4.46%
David & Monique Newlands 7,216,900 3.96%
Unicorn Asset Management Limited 5,759,291 3.16%

Directors’ shareholdings:

Name Number
of shares
% of total
Mr Robert Holt OBE (Chairman) 1,399,810 0.77%
Mr Mike Rogers, Non-Executive Director 260,000 0.14%
Mr Tony Bourne, Non-Executive Director 161,000 0.09%
Mrs Wendy Lawrence, Chief Executive Officer 148,123 0.08%
Mrs Lisa Barter, Finance Director 133,000 0.07%
Mrs Gloria Cooke, Clinical Quality Director 50,500 0.03%

For all shareholder enquiries please contact John Charlton, Group Company Secretary at